We are live on ! Find out more
AC

Armistice Capital Portfolio holdings

AUM $5.62B
1-Year Est. Return 36.06%
This Fund
S&P 500
This Quarter Est. Return
-5.72%
1 Year Est. Return
+36.06%
3 Year Est. Return
+44.14%
5 Year Est. Return
+38.37%
10 Year Est. Return
+188.88%
AUM
$7.95B
AUM Growth
+$407M
Cap. Flow
+$737M
Cap. Flow %
9.28%
Top 10 Hldgs %
63.45%
Holding
409
New
72
Increased
88
Reduced
65
Closed
155

Top Buys

Rank Stock Value
1
ALKS icon
Alkermes
ALKS
+$49.7M
2
SUPN icon
Supernus Pharmaceuticals
SUPN
+$49.3M
3
IMCR icon
Immunocore
IMCR
+$41.4M
4
EXAS
Exact Sciences
EXAS
+$36.8M
5
IMVT icon
Immunovant
IMVT
+$35.1M

Top Sells

Rank Stock Value
1
DCPH
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
+$92.8M
2
KO icon
Coca-Cola
KO
+$36M
3
AGIO icon
Agios Pharmaceuticals
AGIO
+$31.9M
4
POST icon
Post Holdings
POST
+$26.8M
5
NOMD icon
Nomad Foods
NOMD
+$26.4M

Sector Composition

Rank Sector Weight
1 Healthcare 33.06%
2 Consumer Staples 5.21%
3 Consumer Discretionary 4.94%
4 Technology 3.72%
5 Materials 0.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PFGC icon
76
Performance Food Group
PFGC
$18B
$15.9M 0.2%
240,887
+86,497
+56% +$6.03M
ADBE icon
77
Adobe
ADBE
$99.5B
$15.6M 0.2%
28,149
-15,477
-35% -$7.49M
SKX
78
DELISTED
Skechers
SKX
$15.1M 0.19%
219,124
-145,216
-40% -$9.61M
FRPT icon
79
Freshpet
FRPT
$2.93B
$15M 0.19%
115,809
-58,298
-33% -$7M
ENTA icon
80
Enanta Pharmaceuticals
ENTA
$366M
$14.2M 0.18%
1,096,000
-140,000
-11% -$1.89M
EAT icon
81
Brinker International
EAT
$9.17B
$14M 0.18%
193,622
-66,378
-26% -$3.95M
NVDA icon
82
NVIDIA
NVDA
$4.86T
$13.4M 0.17%
108,831
-15,699
-13% -$1.59M
RIGL icon
83
Rigel Pharmaceuticals
RIGL
$681M
$13.3M 0.17%
1,624,000
+88,000
+6% +$921K
DPZ icon
84
Domino's
DPZ
$11.5B
$12.8M 0.16%
+24,761
New +$12.6M
REGN icon
85
Regeneron Pharmaceuticals
REGN
$78.5B
$12.7M 0.16%
12,064
-10,923
-48% -$10.6M
CRVO icon
86
CervoMed
CRVO
$23.9M
$11M 0.14%
640,000
-94,363
-13% -$2.06M
KO icon
87
Coca-Cola
KO
$377B
$10.9M 0.14%
171,244
-581,418
-77% -$36M
CRSP icon
88
CRISPR Therapeutics
CRSP
$4.73B
$10.7M 0.13%
198,357
+6,357
+3% +$368K
TSM icon
89
TSMC
TSM
$2.1T
$10.4M 0.13%
60,000
+4,000
+7% +$607K
S icon
90
SentinelOne
S
$6.53B
$10.4M 0.13%
494,635
+34,510
+8% +$708K
ORLY icon
91
O'Reilly Automotive
ORLY
$72.9B
$10M 0.13%
142,200
+7,050
+5% +$487K
RVTY icon
92
Revvity
RVTY
$12.6B
$9.98M 0.13%
95,180
+20,180
+27% +$2.14M
TGT icon
93
Target
TGT
$65.6B
$9.85M 0.12%
66,519
-5,144
-7% -$809K
PATH icon
94
UiPath
PATH
$6.61B
$9.21M 0.12%
726,520
+353,781
+95% +$6.12M
COTY icon
95
Coty
COTY
$2.42B
$8.88M 0.11%
+886,524
New +$9.5M
TTOO
96
DELISTED
T2 Biosystems, Inc
TTOO
$8.85M 0.11%
+1,658,000
New +$6.92M
ZURA icon
97
Zura Bio
ZURA
$516M
$8.83M 0.11%
2,524,000
+876,000
+53% +$3.57M
CERE
98
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
$8.25M 0.1%
+201,743
New +$8.4M
KYNB
99
Kyntra Bio
KYNB
$27.2M
$7.97M 0.1%
357,440
+40,000
+13% +$1.24M
CMG icon
100
Chipotle Mexican Grill
CMG
$47.2B
$7.83M 0.1%
+125,000
New +$7.77M
2 3
4
5 6

Similar funds

CRC
Curi RMB Capital Chicago, Illinois $5.62B AUM 18.93% 1-Year Est. Return
RMDI
R.M. Davis Inc Portland, Maine $5.63B AUM 21.26% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
DCP
DSM Capital Partners Palm Beach Gardens, Florida $5.66B AUM 27.45% 1-Year Est. Return
EW
Evoke Wealth Los Angeles, California $5.57B AUM 23.85% 1-Year Est. Return
O
Ossiam Paris, France $5.69B AUM 30.95% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $5.56B AUM 17.89% 1-Year Est. Return
DSC
Donald Smith & Co New York $5.56B AUM 47.13% 1-Year Est. Return

Armistice Capital's Q2 2024 Portfolio in Review

As of Q2 2024, Armistice Capital held 409 positions worth $7.95B, up 5.4% from $7.54B the previous quarter. Its ten largest holdings account for 63% of the portfolio.

Armistice Capital deployed $737M of net new capital in Q2 2024, opening 72 new positions and adding to 88 existing holdings. Its largest new stake was Simply Good Foods: 957,163 shares worth $34.6M.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, down from 34% a quarter earlier, followed by Consumer Staples and Consumer Discretionary.

On the sell side, the largest reduction was Coca-Cola, an estimated $36M trimmed.

  • Armistice Capital's largest Q2 2024 buy was Simply Good Foods: 957,163 shares worth $34.6M.
  • Armistice Capital added most to Alkermes in Q2 2024, an estimated $49.7M increase.
  • Armistice Capital's biggest Q2 2024 reduction was Coca-Cola, cutting an estimated $36M.
  • Armistice Capital fully exited Deciphera Pharmaceuticals, Inc. Common Stock in Q2 2024, selling an estimated $92.8M.
  • Armistice Capital's ten largest holdings make up 63% of its $7.95B portfolio in Q2 2024.
  • Armistice Capital opened 72 new positions and closed 155 in Q2 2024.
  • Armistice Capital's portfolio value rose 5.4% quarter-over-quarter to $7.95B.

Based on Armistice Capital's 13F filing for Q2 2024, filed 14 Aug 2024.